Denali Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Denali Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $161k | 11k | 14.52 |
| 2025-06-30 | $189k | 14k | 13.99 |
| 2025-03-31 | $171k | 13k | 13.60 |
| 2024-12-31 | $257k | 13k | 20.38 |
| 2024-09-30 | $367k | 13k | 29.13 |
| 2024-06-30 | $284k | 12k | 23.22 |
| 2024-03-31 | $251k | 12k | 20.52 |
| 2023-12-31 | $263k | 12k | 21.46 |
| 2023-09-30 | $242k | 12k | 20.63 |
| 2023-06-30 | $288k | 9.8k | 29.51 |
| 2023-03-31 | $201k | 8.7k | 23.04 |
| 2022-12-31 | $259k | 8.7k | 29.70 |
| 2022-09-30 | $229k | 7.5k | 30.66 |
| 2022-06-30 | $219k | 7.5k | 29.32 |
| 2022-03-31 | $230k | 7.1k | 32.24 |
| 2021-12-31 | $318k | 7.1k | 44.58 |
| 2021-09-30 | $360k | 7.1k | 50.46 |
| 2021-06-30 | $560k | 7.1k | 78.50 |
| 2021-03-31 | $292k | 5.1k | 57.09 |
| 2020-12-31 | $441k | 5.3k | 83.71 |
| 2020-09-30 | $199k | 5.6k | 35.82 |
| 2020-06-30 | $134k | 5.6k | 24.12 |
| 2020-03-31 | $73k | 4.2k | 17.41 |
| 2019-12-31 | $73k | 4.2k | 17.41 |
| 2019-09-30 | $57k | 3.7k | 15.38 |
| 2019-06-30 | $77k | 3.7k | 20.78 |
| 2019-03-31 | $86k | 3.7k | 23.21 |
| 2018-12-31 | $77k | 3.7k | 20.78 |
| 2018-09-30 | $81k | 3.7k | 21.86 |
| 2018-06-30 | $21k | 1.4k | 15.42 |
| 2018-03-31 | $27k | 1.4k | 19.82 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors